61 related articles for article (PubMed ID: 24780097)
21. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
[TBL] [Abstract][Full Text] [Related]
22. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
[TBL] [Abstract][Full Text] [Related]
23. Cell specific uptake of antiretroviral drugs: AZT coupled to LDL inhibits HIV replication in human macrophages.
Mankertz J; von Baeyer H; Rokos K; Nündel M; Pauli G; Riedel E
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):85-8. PubMed ID: 7757316
[TBL] [Abstract][Full Text] [Related]
24. Deletion of the GPG motif in the HIV type 1 V3 loop does not abrogate infection in all cells.
Su J; Palm A; Wu Y; Sandin S; Höglund S; Vahlne A
AIDS Res Hum Retroviruses; 2000 Jan; 16(1):37-48. PubMed ID: 10628815
[TBL] [Abstract][Full Text] [Related]
25. Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system.
Noë AJ; Malapetsa A; Panasci LC
Mol Pharmacol; 1993 Jul; 44(1):204-9. PubMed ID: 8341272
[TBL] [Abstract][Full Text] [Related]
26. Effect of D-penicillamine on the expression and propagation of the human immunodeficiency virus by H9 T-lymphoblastoid cells.
Bitterlich G; Larcher C; Sölder B; Hengster P; Myones BL; Hofbauer J; Schulz TF; Wachter H; Dierich MP
Arzneimittelforschung; 1989 Aug; 39(8):825-8. PubMed ID: 2818669
[TBL] [Abstract][Full Text] [Related]
27. Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis.
Taneva E; Crooker K; Park SH; Su JT; Ott A; Cheshenko N; Szleifer I; Kiser PF; Frank B; Mesquita PM; Herold BC
Antimicrob Agents Chemother; 2015 Dec; 60(3):1667-75. PubMed ID: 26711762
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS
AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+.
Davis DA; Branca AA; Pallenberg AJ; Marschner TM; Patt LM; Chatlynne LG; Humphrey RW; Yarchoan R; Levine RL
Arch Biochem Biophys; 1995 Sep; 322(1):127-34. PubMed ID: 7574666
[TBL] [Abstract][Full Text] [Related]
30. Selection of human immunodeficiency virus type 1 resistance against the pyranodipyrimidine V-165 points to a multimodal mechanism of action.
Hombrouck A; Hantson A; van Remoortel B; Michiels M; Vercammen J; Rhodes D; Tetz V; Engelborghs Y; Christ F; Debyser Z; Witvrouw M
J Antimicrob Chemother; 2007 Jun; 59(6):1084-95. PubMed ID: 17470918
[TBL] [Abstract][Full Text] [Related]
31. Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription.
Jang S; Hyun S; Kim S; Lee S; Lee IS; Baba M; Lee Y; Yu J
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10086-9. PubMed ID: 25056130
[TBL] [Abstract][Full Text] [Related]
32. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
Hulme AE; Kelley Z; Foley D; Hope TJ
J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
[TBL] [Abstract][Full Text] [Related]
33. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
[TBL] [Abstract][Full Text] [Related]
34. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
35. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection.
Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
J Virol; 2017 May; 91(9):. PubMed ID: 28202766
[TBL] [Abstract][Full Text] [Related]
37. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
38. The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications.
Gordts SC; Férir G; D'huys T; Petrova MI; Lebeer S; Snoeck R; Andrei G; Schols D
PLoS One; 2015; 10(7):e0131219. PubMed ID: 26132818
[TBL] [Abstract][Full Text] [Related]
39. Diffusion, not uptake, limits glycine concentration in the synaptic cleft.
Titmus MJ; Korn H; Faber DS
J Neurophysiol; 1996 Apr; 75(4):1738-52. PubMed ID: 8727410
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3',3'-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in Gag.
Zhou J; Chen CH; Aiken C
J Virol; 2006 Dec; 80(24):12095-101. PubMed ID: 17035324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
